Immediate Impact

1 from Science/Nature 65 standout
Sub-graph 1 of 25

Citing Papers

Bimekizumab versus ustekinumab for the treatment of moderate to severe plaque psoriasis (BE VIVID): efficacy and safety from a 52-week, multicentre, double-blind, active comparator and placebo controlled phase 3 trial
2021 Standout
National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study
2020 Standout
2 intermediate papers

Works of Marjorie Hatch being referenced

TRIVIAL OR TERRIBLE? THE PSYCHOSOCIAL IMPACT OF PSORIASIS
1995

Author Peers

Author Last Decade Papers Cites
Marjorie Hatch 111 6 32 75 71 10 260
Patryk Łakuta 105 6 8 123 39 16 284
Anastasia Drakos 214 14 12 28 93 8 333
H. Devrimci-Ozguven 111 4 153 8 6 300
Emanuele Tarolla 161 7 83 19 23 15 323
Floris Kraaimaat 130 11 30 18 74 12 279
Frank J. Don 138 2 12 12 125 10 254
Meghan L. McPhie 156 20 6 7 35 18 308
Lloyd A. Taylor 46 8 23 8 6 12 288
Elly McGrath 54 2 20 4 41 10 257
Pekka Koistinen 100 2 26 55 18 15 326

All Works

Loading papers...

Rankless by CCL
2026